Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.
about
Challenges in the treatment of HIV and HCV coinfection.Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type.Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Antiviral treatment for hepatitis C virus infection after liver transplantation.Molecular methods of hepatitis C genotyping.Prevention of hepatitis C recurrence after liver transplantation: An update.Photoactivated composite biomaterial for soft tissue restoration in rodents and in humansInterferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.Living-donor liver transplantation and hepatitis CRecurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.Rejection under alpha interferon therapy in liver transplant recipients.Therapeutic management of recurrent hepatitis C after liver transplantation.PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a retrospective review.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.Hepatitis C virus and liver transplantation: where do we stand?Antihepatitis C virus therapy in liver transplanted patients.Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.Viral hepatitis in solid organ transplantation.Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin.Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy.Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.Liver transplantation and hepatitis CHepatitis C and liver transplantation
P2860
Q30389282-902C35B7-BE73-4E75-90D9-BCC2CF96BF21Q33381410-877D180F-5BF5-4CA8-8821-F1ED537AD667Q34093754-21D8D9FA-9090-4C2A-A2A2-8BFF1D26B447Q34340293-02754C17-40E3-46D1-807A-54D7A382C6E1Q36192689-312E9D80-5102-473A-84A6-349980AE8D68Q36220172-AB7B171B-58A0-4EB2-BC1F-A523BC766637Q36298905-749DE620-DE60-428A-9EAE-BB269E4A8AB6Q36530402-028130D1-E370-48D2-9D76-BBA917FB97D5Q36587253-0BC438E4-85F7-4720-9C96-1523287D3B33Q36655931-7BDE3A36-1221-4339-B031-F3B27D493E9AQ36709673-5501B8FD-BB79-4EE5-B33F-90B59D0C64F0Q36758660-D9299C8E-D50C-4C80-AAB8-775C516FD1CDQ37077437-3076E49A-565C-484B-9E42-4FC94EDD0EC7Q37222388-4586BC1D-A8E9-4FA1-9874-11DE62965C42Q37973516-44FE68DF-EAAB-4051-8F45-EBF3D220987BQ38551818-0A703996-7157-45D2-BC12-70D005B2F9D6Q39887907-B51ED49A-BDCB-4156-A44A-DC554EF7BAC0Q41860936-CB0D614F-4FC4-465E-B82C-B6703D17A714Q42272319-F1FD9D1B-F7F4-4910-8C65-C2EEB01C457FQ42978531-5259F545-FDC8-4D32-8669-55530F876107Q42993598-3B7F95DF-C5D6-49CF-AC05-805DFAEBA5D8Q43001526-50BE34FB-4E04-4576-AD17-1326FB8A7FC9Q50575004-6253629F-DA9B-4DC7-9C57-4105573C120BQ50579191-393B4C3C-F6BC-431B-BBE7-05EFA1DAF06CQ54544776-E20857F9-5FF9-4D8D-84A9-8D0CEB12A520Q58704499-CDA0C222-0214-4EE2-B930-62E8443CBC6DQ59098576-17239ED0-A7C5-420F-B9D3-2E49926C0054
P2860
Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@ast
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@en
type
label
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@ast
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@en
prefLabel
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@ast
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@en
P2093
P2860
P1476
Pegylated interferon alpha-2b ...... nsplant recurrent hepatitis C.
@en
P2093
A Benedict Cosimi
Andrew S Ross
Atul K Bhan
Manuel Pascual
Michael Thiim
P2860
P304
P356
10.1046/J.1399-0012.2003.00145.X
P577
2004-04-01T00:00:00Z